|本期目录/Table of Contents|

[1]刘甫,李军普,李绍深,等.原肌球蛋白的重组表达、鉴定及与免疫球蛋白E结合能力分析[J].天津医科大学学报,2020,26(03):256-260.
 LIU Fu,LI Jun-pu,LI Shao-shen,et al.Recombinant expression, identification and immunoglobulin E binding analysis of tropomyosin Pen a 1[J].Journal of Tianjin Medical University,2020,26(03):256-260.
点击复制

原肌球蛋白的重组表达、鉴定及与免疫球蛋白E结合能力分析(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
26卷
期数:
2020年03期
页码:
256-260
栏目:
技术与方法
出版日期:
2020-06-10

文章信息/Info

Title:
Recombinant expression, identification and immunoglobulin E binding analysis of tropomyosin Pen a 1
文章编号:
1006-8147(2020)03-0256-05
作者:
刘甫1李军普1李绍深2李智伟1孔德玉3白虹4李会强1
(1.天津医科大学医学技术学院,天津300203;2.天津市中医药研究院附属长征医院检验科,天津300120;3.天津市港口医院检验科,天津300456;4.天津医科大学基础医学院免疫学系,天津300070)
Author(s):
LIU Fu1 LI Jun-pu1 LI Shao-shen2 LI Zhi-wei1 KONG De-yu3 BAI Hong4 LI Hui-qiang1
(1. Medical Technology College, Tianjin Medical University,Tianjin 300203,China; 2. Department of Clinical Laboratory,Tianjin Institute of Traditional Chinese Medicine, Tianjin 300120,China;3.Department of Clinical Laboratory,Tianjin Port Hospital,Tianjin 300456,China; 4.Department of Immunology, School of Basic Medical Sciences,Tianjin Medical University,Tianjin 300070, China)
关键词:
贝类过敏重组过敏原原肌球蛋白(Pen a 1)免疫球蛋白E
Keywords:
shellfish allergyrecombinant allergentropomyosin (Pen a 1)IgE
分类号:
R446.61
DOI:
-
文献标志码:
A
摘要:
目的:在大肠杆菌中重组表达贝类主要过敏原—原肌球蛋白(Pen a 1),并且评估其IgE结合活性。方法:首先基于Pen a 1 的已知序列人工合成Pen a 1 基因,其次将其与质粒pET-28a连接以构建重组表达质粒pET-28a(+)-Pen a 1,经测序、酶切鉴定后导入表达宿主E. coli BL21(DE3)细胞中。通过IPTG诱导,重组表达Pen a 1蛋白,镍柱纯化表达产物,并采用SDS-PAGE电泳及质谱技术鉴定所得重组蛋白。最后应用贝类过敏患者采用LICA技术检测该重组蛋白的IgE结合活性。结果:PCR结果表明,目的基因全长为930 bp,与理论预测值一致。SDS-PAGE电泳结果显示,目的蛋白在宿主菌内以可溶性蛋白的形式高效表达,分子量约为 36 kD ,大小与理论值相符。质谱鉴定结果进一步说明所得的重组蛋白为原肌球蛋白Pen a 1。免疫分析结果表明该蛋白具有较高的IgE结合能力。结论:成功表达、纯化出有良好免疫学活性的重组原肌球蛋白Pen a 1,为进一步研究Pen a 1在贝类动物如虾类过敏的诊断和治疗中作用奠定基础。
Abstract:
Objective: To clone and express Pen a 1 as a major allergen from Penaeus aztecus in E.coli, and to analyze its immunoglobulin E (IgE)binding ability. Methods: The gene coding Pen a 1 protein sequences were synthesized and cloned into the Bam HI and Hind III sites of pET28a (+) expression vector. After sequencing and identified by restriction endonuclease digestion, the verified pET-28a(+)-Pen a 1 was transformed into E. coli BL21 cells. The recombinant expression of Pen a 1 was induced by IPTG. The recombinant protein was purified using Ni+-NTA affinity column chromatography, characterized by sodium dodecyl sulphate SDS-PAGE and MS, and tested by LICA for IgE reactivity with sera from individuals with shellfish allergy. Results: PCR analysis showed that the size of the target gene fragment was about 930 bp, which was consistent with the theoretical predictions. SDS-PAGE showed that the recombinant protein was highly expressed in the form of soluble protein in E. coli, and its molecular weight was about 36 kD, which was in accordance with the theoretical value. The results of mass spectrometry further revealed that the expression product was tropomyosin Pen a 1. Immunological analysis indicated the protein had high IgE binding ability. Conclusion: Recombinant tropomyosin Pen a 1 with good immunogenicity was successfully produced, which laid the foundation for further study on the role of Pen a 1 in the diagnosis and treatment of allergies including shrimp allergy.

参考文献/References:

[1] El-Qutob D. Shrimp allergy: beyond avoidance diet[J]. Eur Ann Allergy Clin Immunol, 2017, 49(6): 252
[2] Ruethers T, Taki A C, Johnston E B, et al. Seafood allergy: A comprehensive review of fish and shellfish allergens[J]. Mol Immunol, 2018, 100: 28
[3] Borres M P, Maruyama N, Sato S, et al. Recent advances in component resolved diagnosis in food allergy[J]. Allergol Int, 2016, 65(4): 378
[4] Faber M A, Pascal M, El Kharbouchi O, et al. Shellfish allergens: tropomyosin and beyond[J]. Allergy, 2017, 72(6): 842
[5] Tscheppe A, Breiteneder H. Recombinant allergens in structural biology, diagnosis, and immunotherapy[J]. Int Arch Allergy Immunol, 2017, 172(4): 187
[6] Mas S, Boissy P, Monsalve R I, et al. A recombinant Sal k 1 isoform as an alternative to the polymorphic allergen from salsola Kali pollen for allergy diagnosis[J]. Int Arch Allergy Immunol, 2015, 167(2): 83
[7] Pascal M, Grishina G, Yang A C, et al. Molecular diagnosis of shrimp allergy: efficiency of several allergens to predict clinical reactivity[J]. J Allergy Clin Immunol Pract, 2015, 3(4): 521
[8] Bian Y, Liu C, She T, et al. Development of a light-initiated chemiluminescent assay for the quantitation of sIgE against egg white allergens based on component-resolved diagnosis[J]. Anal Bioanal Chem, 2018, 410(5): 1501
[9] Myrset H R, Barletta B, Di Felice G A, et al. Structural and immunological characterization of recombinant Pan b 1, a major allergen of northern shrimp, pandalus borealis[J]. Int Arch Allergy Immunol, 2013, 160(3): 221
[10] Bauermeister K, Wangorsch A, Garoffo L P, et al. Generation of a comprehensive panel of crustacean allergens from the North Sea Shrimp Crangon crangon[J]. Mol Immunol, 2011, 48(15/16): 1983
[11] Rohrback S E, Wheatly M G, Gillen C M. Calcium binding to Procambarus clarkii sarcoplasmic calcium binding protein splice variants[J]. Comp Biochem Physiol B-Biochem Mol Biol, 2015, 179: 57
[12] Zhang Y, Zhu L, Li S, et al. Identification of the major allergenic epitopes of Eriocheir sinensis roe hemocyanin: A novel tool for food allergy diagnoses[J]. Mol Immunol, 2016, 74: 125
[13] Ayuso R, Reese G, Leong-Kee S, et al. Molecular basis of arthropod cross-reactivity: IgE-binding cross-reactive epitopes of shrimp, house dust mite and cockroach tropomyosins[J]. Int Arch Allergy Immunol, 2002, 129(1): 38
[14] DeWitt AM, Mattsson L, Lauer I, et al. Recombinant tropomyosin from Penaeus aztecus (rPen a 1) for measurement of specific immunoglobulin E antibodies relevant in food allergy to crustaceans and other invertebrates[J]. Mol Nutr Food Res, 2004, 48: 370
[15] Gamez C, Sanchez-Garcia S, Ibanez M D, et al. Tropomyosin IgE-positive results are a good predictor of shrimp allergy[J]. Allergy, 2011, 66(10): 1375
[16] Van Hage M, Hamsten C, Valenta R. ImmunoCAP assays: Pros and cons in allergology[J]. J Allergy Clin Immunol, 2017, 140(4): 974
[17] Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy[J]. J Allergy Clin Immunol, 2015, 136(3): 556
[18] Valenta R, Campana R, Focke-Tejkl M. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future[J]. J Allergy Clin Immunol, 2016, 137(2): 351
[19] Kamath S D, Thomassen M R, Saptarshi S R, et al. Molecular and immunological approaches in quantifying the air-borne food allergen tropomyosin in crab processing facilities[J]. Int J Hyg Environ Health, 2014, 217(7): 740
[20] Mahajan A, Youssef L A, Cleyrat C, et al. Allergen valency, dose, and FcERI occupancy set thresholds for secretory responses to pen a 1 and motivate design of hypoallergens[J]. J Immunol, 2017, 198(3): 1034

相似文献/References:

备注/Memo

备注/Memo:
基金项目 国家自然科学基金资助项目(81772259);天津医科大学校内科研基金资助项目(2110/2JY018)
作者简介 刘甫(1985-),男,助理实验师,硕士在读,研究方向:免疫学;通信作者:白虹,E-mail:Hongbai25@163.com;李会强,E-mail:lihuiqiang1965@163.com。
更新日期/Last Update: 2020-06-13